Don't miss our weekly PhD newsletter | Sign up now Don't miss our weekly PhD newsletter | Sign up now

  Hypothalamic Glial Cell Control of Glucose Homeostasis in Diabetes - Biomedicine, PhD (GW4 BioMed MRC DTP)


   Medical School

This project is no longer listed on FindAPhD.com and may not be available.

Click here to search FindAPhD.com for PhD studentship opportunities
  Dr C Beall  No more applications being accepted  Competition Funded PhD Project (European/UK Students Only)

About the Project

About
Supervisory Team: Dr Craig Beall
Dr Kate Ellacott, Dr Mino Belle, Prof Tony Pickering
Location: Exeter, Medical School

Project
The hypothalamus contains various neuronal populations controlling aspects of homeostasis, including systemic glucose regulation. One specific region of the hypothalamus known as the ventromedial hypothalamus (VMH) contains neurons that are excited by increasing glucose levels, known as glucose-excited (GE) neurons. Other neurons of the VMH are inhibited by increasing glucose levels, termed glucose-inhibited (GI) neurons. These cells work in concert to orchestrate the whole body response to changing glucose levels, altering release of the main glucose-regulating hormones, insulin and glucagon, which decrease and increase blood glucose levels, respectively. What is not known is whether glial cells, neuromodulatory but non-electrically active cells within the brain, also play a role in detecting changes in glucose and helping GE and GI neurons to function.

Advances in technologies enabling regulation of specific brain cell populations has increased our understanding of glial cell function. It has become increasingly apparent that glial cells do more than just support neurons but also release chemical signals termed gliotransmitters that alter aspects of neuronal activity. For example, glial cells within the hypothalamus have, over the past 3 years, been shown to regulate feeding. What is much less clear is how glial cells regulate blood glucose levels when glucose levels increase or decrease too much. This happens frequently in people with diabetes. The aim of this PhD is to determine how glial cells, specifically astrocytes, may detect changes in glucose levels and contribute to regulation of whole body glucose homeostasis.

To achieve this, the student will utilise a number of cutting edge technologies. Firstly, in ex-vivo slices, the student will measure neuronal activity across the VMH using a perforated multi-electrode array recordings whilst manipulating astrocytes with pharmacological or genetic approaches. They will examine whether increasing or decreasing astrocyte activity alters responses of GE and GI neurons to changes in glucose concentration.

Secondly, to determine whether neuronal activity alters astrocyte activity, the student will utilise two-photon imaging with calcium-sensitive dyes to monitor changes in astrocyte activity, whilst changing glucose levels or altering neurotransmitter (GABA and glutamate) signalling.

Thirdly, to determine how glial cells alter glucose homeostasis, the student will use advanced microvascular surgery to perform dual carotid artery and jugular vein catheterisation. This allows simultaneous infusion of insulin and glucose to accurately control glucose levels, whilst sampling blood for analysis of glucose and gluco-regulatory hormones. By combining this with chemogenetic viral vector injection into the hypothalamus to express an engineered receptor, the student can manipulate astrocyte activity using a synthetic drug, whilst clamping glucose at a desired level. Thus, they will determine the impact of local glial cell activity on whole body physiology. These experiments will fill an important piece of the glucose homeostasis jigsaw potentially providing new targets for treatment. Moreover, these multidisciplinary approaches will generate high impact publications and provide an excellent training experience for the student.

Start date: October 2018

Most studentships will be 3.5 years full time or up to 7 years part-time, and can be longer where additional training is undertaken.


How to apply
APPLICATIONS OPEN ON 25 SEPTEMBER AND CLOSE AT 17:00 ON 24 NOVEMBER 2017.

IMPORTANT: In order to apply for this project, you should apply using the DTP’s online application form. More information on the application process may be found here: http://www.gw4biomed.ac.uk/projects-2/for-students/

You do NOT need to apply to the University of Exeter at this stage – only those applicants who are successful in obtaining an offer of funding from the DTP will be required to submit an application to study at Exeter.


Funding Notes

Stipend matching UK Research Council National Minimum (£14,553 p.a. for 2017/18, updated each year) plus UK/EU tuition fees


UK and EU applicants who have been residing in the UK since September 2015 will be eligible for a full award; those who do not meet this residency requirement may be eligible for a fees-only award.

Applicants who are classed as International for tuition fee purposes are not eligible for funding.

Where will I study?